| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022973891 |
| P356 | DOI | 10.1007/S11046-014-9763-3 |
| P698 | PubMed publication ID | 24947167 |
| P50 | author | Emilio Bouza | Q37376561 |
| P2093 | author name string | Jesús Guinea | |
| P2860 | cites work | Galactomannan detection for invasive aspergillosis in immunocompromized patients | Q24240734 |
| High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease | Q24628838 | ||
| Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients | Q63859727 | ||
| Comparison of clinical and post-mortem findings in intensive care unit patients | Q64126827 | ||
| Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia | Q73336907 | ||
| Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay | Q80179470 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance | Q80312940 | ||
| Clinical diagnoses and autopsy findings: discrepancies in critically ill patients* | Q82039738 | ||
| Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance | Q82275235 | ||
| Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients | Q82505428 | ||
| β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis | Q83514901 | ||
| Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003) | Q83938057 | ||
| Enteral nutrition may cause false-positive results of Aspergillus galactomannan assay in absence of gastrointestinal diseases | Q84220455 | ||
| Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples | Q84258158 | ||
| Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases | Q84839346 | ||
| A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-g | Q84999464 | ||
| Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease | Q86487823 | ||
| Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome | Q24811601 | ||
| Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review | Q27013923 | ||
| Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease | Q28251330 | ||
| Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome | Q28264458 | ||
| Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation | Q28293483 | ||
| Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients | Q30978790 | ||
| Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan | Q33592749 | ||
| Aspergillus PCR: one step closer to standardization. | Q33769584 | ||
| Histopathologic diagnosis of fungal infections in the 21st century | Q33868769 | ||
| Five-years surveillance of invasive aspergillosis in a university hospital | Q33926071 | ||
| Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia | Q34190425 | ||
| Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis | Q34385038 | ||
| Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis | Q34514484 | ||
| Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer | Q34688953 | ||
| Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis | Q35066867 | ||
| Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay | Q35599066 | ||
| Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis | Q35636789 | ||
| Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. | Q35668212 | ||
| Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis | Q35789251 | ||
| Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay | Q35806844 | ||
| Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity | Q35867884 | ||
| Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients | Q35913870 | ||
| Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts | Q36098515 | ||
| Nonresolving pneumonia in steroid-treated patients with obstructive lung disease | Q36304473 | ||
| The link between fungi and severe asthma: a summary of the evidence. | Q36409578 | ||
| Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study | Q36633947 | ||
| Galactomannan antigen detection in the diagnosis of invasive aspergillosis | Q36691715 | ||
| Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders | Q36774247 | ||
| Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis | Q36826633 | ||
| Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients | Q37051568 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia | Q37302104 | ||
| Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis | Q37380385 | ||
| Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis | Q37450831 | ||
| Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid | Q37702655 | ||
| Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review | Q37746547 | ||
| Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis | Q37780940 | ||
| Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients | Q38089915 | ||
| Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial | Q38103680 | ||
| Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis | Q38116964 | ||
| Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens | Q39901663 | ||
| Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis | Q39984946 | ||
| Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management | Q40428561 | ||
| Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. | Q41791143 | ||
| Growth of Aspergillus in blood cultures: proof of invasive aspergillosis in patients with chronic obstructive pulmonary disease? | Q42276893 | ||
| Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis | Q42773149 | ||
| Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid | Q42912557 | ||
| False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics | Q43146182 | ||
| Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients | Q43910464 | ||
| Prevalence of fungal infections detected from biopsies and autopsies in the past 11 years at the University Hospital Joan XXIII in Tarragona, Spain | Q44045225 | ||
| Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan | Q44183804 | ||
| Disseminated aspergillosis in intensive care unit patients: an autopsy study | Q44392075 | ||
| Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination | Q44484728 | ||
| Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. | Q44634809 | ||
| The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis | Q44718453 | ||
| Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey | Q45018793 | ||
| Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. | Q45366904 | ||
| A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients | Q46059175 | ||
| Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. | Q46426332 | ||
| Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay | Q46503389 | ||
| False-positive Aspergillus antigenemia due to blood product conditioning fluids. | Q50510671 | ||
| Biopsy procedures for molecular tissue diagnosis of invasive fungal infections. | Q51174142 | ||
| Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. | Q51175429 | ||
| Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals | Q51748116 | ||
| Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies | Q53167712 | ||
| Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis | Q53458650 | ||
| Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. | Q53746276 | ||
| Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. | Q54419355 | ||
| Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease | Q57053335 | ||
| Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 | ||
| Post-surgical invasive aspergillosis: An uncommon and under-appreciated entity | Q57569130 | ||
| Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation ofAspergillusspp | Q57569197 | ||
| Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients | Q57937345 | ||
| P433 | issue | 5-6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspergillosis | Q259626 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 403-416 | |
| P577 | publication date | 2014-06-20 | |
| P1433 | published in | Mycopathologia | Q15763210 |
| P1476 | title | Current challenges in the microbiological diagnosis of invasive aspergillosis | |
| P478 | volume | 178 |
| Q85693074 | Advances against aspergillosis: biology, host response, diagnosis and treatment |
| Q49604618 | Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. |
| Q37697287 | Fulminant Laryngeal-tracheobronchial-pulmonary Aspergillosis: A Rare and Fatal Complication in Allogeneic Hematopoietic Stem Cell Transplantation Recipients |
| Q35781522 | Immunochemical analysis of fumigaclavine mycotoxins in respiratory tissues and in blood serum of birds with confirmed aspergillosis. |
| Q90429595 | Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response |
| Q39206915 | Invasive mould infections in the ICU setting: complexities and solutions |
| Q41309185 | Liquid-based cytopathology test as a novel method to identify Aspergillus in patients with pulmonary aspergillosis |
| Q97427835 | Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment |
| Q40171946 | Sputum and bronchial secretion samples are equally useful as bronchoalveolar lavage samples for the diagnosis of invasive pulmonary aspergillosis in selected patients |
Search more.